Note 1: Ascites with malignant cells changes FIGO stages I and II to IC and IIC, respectively. Ascites, NOS is considered negative.
Note 2: "Both extension to and discontinuous metastasis to any of the following pelvic organs is considered FIGO Stage II and coded in the range 50-65: adnexae, NOS; bladder, bladder serosa; broad ligament (mesovarium); cul-de-sac; fallopian tubes; parametrium; pelvic peritoneum; pelvic wall; rectum; sigmoid colon; sigmoid mesentery; ureter; uterus; uterine serosa.
Note 3: Peritoneal implants outside the pelvis (codes 70-73) must be microscopically confirmed. Peritoneal implants may also be called seeding, salting, talcum powder appearance, or studding.
Note 4: If implants are mentioned, determine whether they are in the pelvis or in the abdomen and code appropriately (60-64) or (70-73). If the location is not specified, code as 75.
Note 5: Both extension to and discontinuous metastasis to any of the following abdominal organs is considered FIGO Stage III and coded in the range 70-75: abdominal mesentery; diaphragm; gallbladder; infracolic omentum; kidneys; large intestine except rectum and sigmoid colon; liver (peritoneal surface); omentum; pancreas; pericolic gutter; peritoneum, NOS; small intestine; spleen; stomach; ureters.
Note 6: Excludes parenchymal liver nodules, which are coded in CS Mets at DX
Note 7: Since "cancer cells in ascites or in peritoneal washings" was not specifically categorized in the 1977 Summary Stage Guide, it is unclear to which stage previous cases may have been coded.
Code | Description | TNM | SS77 | SS2000 |
---|---|---|---|---|
00 | In situ; pre-invasive; non-invasive; intraepithelia | Tis | IS | IS |
10 | Tumor limited to one ovary, capsule intact, no tumor on ovarian surface, no malignant cells in ascites or peritoneal washings FIGO Stage IA |
T1a | L | L |
20 | Tumor limited to both ovaries, capsule(s) intact, no tumor on ovarian surface, no malignant cells in ascites or peritoneal washings FIGO Stage IB |
T1b | L | L |
30 | Tumor limited to ovaries, unknown if capsule(s) ruptured or if one or both ovaries involved Localized, NOS FIGO Stage I, NOS |
T1NOS | L | L |
35 | Tumor limited to ovary(ies), capsule(s) ruptured FIGO Stage 1C |
T1c | L | RE |
36 | Tumor on ovarian surface FIGO Stage 1C |
T1c | D | RE |
41 | Tumor limited to ovary(ies) with malignant cells in ascites or peritoneal washings FIGO Stage IC |
T1c | RE | RE |
43 | (35) + (41) FIGO Stage IC |
T1c | RE | RE |
44 | (36) + any of [(35) or (41)] FIGO Stage 1C |
T1c | D | RE |
50 | Extension to or implants on (but no malignant cells in ascites or peritoneal washings):
|
T2a | RE | RE |
52 | Extension to or implants on (but no malignant cells in ascites or peritoneal washings):
|
T2a | D | RE |
60 | Extension to or implants on other pelvic structures (but no malignant cells in ascites or peritoneal washings):
|
T2b | RE | RE |
61 | Extension to or implants on other pelvic structures (but no malignant cells in ascites or peritoneal washings):
|
T2b | D | RE |
62 | [(50) and/or (60)] with malignant cells in ascites or peritoneal washings FIGO Stage IIC |
T2c | RE | RE |
63 | [(52 and/or 60)] with malignant cells in ascites or peritoneal washings FIGO Stage IIC |
T2c | D | RE |
64 | (61) with malignant cells in ascites or peritoneal washings FIGO IIC |
T2c | D | RE |
65 | Tumor involves one OR both ovaries with pelvic extension, NOS FIGO Stage II, NOS |
T2NOS | RE | RE |
70 | Microscopic peritoneal implants beyond pelvis, including peritoneal surface/capsule of liver FIGO Stage IIIA (See Note 5) |
T3a | D | D |
71 | Macroscopic peritoneal implants beyond pelvis, less than or equal to 2 cm in diameter, including peritoneal surface of liver FIGO Stage IIIB (See Note 5) |
T3b | D | D |
72 | Peritoneal implants beyond pelvis, greater than 2 cm in diameter, including peritoneal surface of liver (liver capsule) FIGO Stage IIIC (See Note 5) |
T3c | D | D |
73 | Tumor involves one or both ovaries with microscopically confirmed peritoneal metastasis outside the pelvis, NOS FIGO Stage III, NOS (See Note 5) |
T3NOS | D | D |
75 | Peritoneal implants, NOS (See Note 5) | T3NOS | D | D |
80 | Further contiguous extension | T3NOS | D | D |
95 | No evidence of primary tumor | T0 | U | U |
99 |
|
TX | U | U |